TY - JOUR
T1 - Cerebrovascular disease in childhood cancer survivors A Children's Oncology Group Report
AU - Morris, B.
AU - Partap, S.
AU - Yeom, K.
AU - Gibbs, I. C.
AU - Fisher, P. G.
AU - King, A. A.
N1 - Funding Information:
Dr. Morris, Dr. Partap, and Dr. Yeom report no disclosures. Dr. Gibbs serves on a clinical advisory board for and has received speaker honoraria from Accuray, Inc.; serves on the editorial board of Radiation Medicine Rounds ; and has received research support from the Leach Foundation and the Cyberknife Society. Dr. Fisher serves/has served on editorial boards of the Journal of Pediatrics and the Journal of Clinical Oncology . Dr. King receives research support from the NIH [NHLBI K23HL079073 (PI)], HRSA [H46MC09231-01-00 (PI)], the Doris Duke Charitable Foundation, and the American Society of Hematology.
PY - 2009/12
Y1 - 2009/12
N2 - BACKGROUND: Curative therapy for childhood cancer has dramatically improved over past decades. Therapeutic radiation has been instrumental in this success. Unfortunately, irradiation is associated with untoward effects, including stroke and other cerebrovascular disease (CVD). The Children's Oncology Group (COG) has developed guidelines for screening survivors at risk for persistent or late sequelae of cancer therapy. OBJECTIVE:S This review summarizes the pathophysiology and relevant manifestations of radiation-induced CVD and outlines the specific patient groups at risk for early-onset stroke. The reader will be alerted to the availability of the COG recommendations for monitoring, and, when applicable, specific screening and treatment recommendations will be highlighted. METHODS: A multidisciplinary task force critically reviewed the existing literature and scored the evidence to establish the current COG guidelines for monitoring health of survivors treated with head and neck irradiation. RESULTS: Previous head and neck exposure to therapeutic radiation is associated with latent CVD and increased risk for stroke in some patient groups. Common manifestations of radiation-induced CVD includes steno-occlusive disease, moyamoya, aneurysm, mineralizing microangiopathy, vascular malformations, and strokelike migraines. CONCLUSION Risk for stroke is increased in survivors of pediatric CNS tumors, Hodgkin lymphoma, and acute lymphoblastic leukemia who received radiation to the brain and/or neck. As the population of survivors ages, vigilance for stroke and cerebrovascular disease needs to continue based on specific exposures during curative cancer therapy.
AB - BACKGROUND: Curative therapy for childhood cancer has dramatically improved over past decades. Therapeutic radiation has been instrumental in this success. Unfortunately, irradiation is associated with untoward effects, including stroke and other cerebrovascular disease (CVD). The Children's Oncology Group (COG) has developed guidelines for screening survivors at risk for persistent or late sequelae of cancer therapy. OBJECTIVE:S This review summarizes the pathophysiology and relevant manifestations of radiation-induced CVD and outlines the specific patient groups at risk for early-onset stroke. The reader will be alerted to the availability of the COG recommendations for monitoring, and, when applicable, specific screening and treatment recommendations will be highlighted. METHODS: A multidisciplinary task force critically reviewed the existing literature and scored the evidence to establish the current COG guidelines for monitoring health of survivors treated with head and neck irradiation. RESULTS: Previous head and neck exposure to therapeutic radiation is associated with latent CVD and increased risk for stroke in some patient groups. Common manifestations of radiation-induced CVD includes steno-occlusive disease, moyamoya, aneurysm, mineralizing microangiopathy, vascular malformations, and strokelike migraines. CONCLUSION Risk for stroke is increased in survivors of pediatric CNS tumors, Hodgkin lymphoma, and acute lymphoblastic leukemia who received radiation to the brain and/or neck. As the population of survivors ages, vigilance for stroke and cerebrovascular disease needs to continue based on specific exposures during curative cancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=73349099025&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e3181c17ea8
DO - 10.1212/WNL.0b013e3181c17ea8
M3 - Review article
C2 - 19812380
AN - SCOPUS:73349099025
SN - 0028-3878
VL - 73
SP - 1906
EP - 1913
JO - Neurology
JF - Neurology
IS - 22
ER -